ATE460394T1 - 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten - Google Patents

5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten

Info

Publication number
ATE460394T1
ATE460394T1 AT01964654T AT01964654T ATE460394T1 AT E460394 T1 ATE460394 T1 AT E460394T1 AT 01964654 T AT01964654 T AT 01964654T AT 01964654 T AT01964654 T AT 01964654T AT E460394 T1 ATE460394 T1 AT E460394T1
Authority
AT
Austria
Prior art keywords
derivatives
diseases
inflammatory
treating diseases
asa
Prior art date
Application number
AT01964654T
Other languages
German (de)
English (en)
Inventor
Nnochiri Ekwuribe
Elizabeth Malson
Jennifer Riggs-Sauthier
Original Assignee
Biocon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Ltd filed Critical Biocon Ltd
Application granted granted Critical
Publication of ATE460394T1 publication Critical patent/ATE460394T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01964654T 2000-08-29 2001-08-28 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten ATE460394T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22868200P 2000-08-29 2000-08-29
PCT/US2001/041910 WO2002018330A1 (en) 2000-08-29 2001-08-28 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith

Publications (1)

Publication Number Publication Date
ATE460394T1 true ATE460394T1 (de) 2010-03-15

Family

ID=22858177

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01964654T ATE460394T1 (de) 2000-08-29 2001-08-28 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten

Country Status (10)

Country Link
US (1) US6458776B1 (cg-RX-API-DMAC7.html)
EP (1) EP1313699B1 (cg-RX-API-DMAC7.html)
JP (1) JP5112595B2 (cg-RX-API-DMAC7.html)
AT (1) ATE460394T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001285489A1 (cg-RX-API-DMAC7.html)
CA (1) CA2421114C (cg-RX-API-DMAC7.html)
DE (1) DE60141520D1 (cg-RX-API-DMAC7.html)
IL (2) IL154537A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03001786A (cg-RX-API-DMAC7.html)
WO (1) WO2002018330A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2495537C (en) 2000-08-29 2010-03-30 Nobex Corporation Immunoregulatory compounds and derivatives and methods of treating diseases therewith
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
AU2003259381A1 (en) * 2002-08-29 2004-03-19 University Of Southampton Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases
US20060264408A1 (en) * 2003-03-06 2006-11-23 Haj-Yehia Abdullah I Sod minic multifunctional compounds for treating inflammatory bowel disease
SE0300807L (sv) * 2003-03-25 2004-03-30 Sven Kindblom Stötdämpare för höjdreglering
PL1651249T3 (pl) 2003-07-23 2013-04-30 Novartis Ag Zastosowanie kalcytoniny w zapaleniu kości i stawów
NZ549661A (en) * 2004-02-06 2010-07-30 Pharmatel R & D Pty Ltd As Tru Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome
DE602005022175D1 (de) * 2004-05-28 2010-08-19 Salix Pharmaceuticals Inc Prävention, behandlung und linderung strahlungsinduzierter enteritis
EP1773767B1 (en) * 2004-07-07 2016-03-09 Biocon Limited Synthesis of azo bonded immunoregulatory compounds
US7498355B2 (en) * 2005-05-27 2009-03-03 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
US7741359B2 (en) * 2005-05-27 2010-06-22 Antibe Therapeutics Inc. Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
WO2006125293A1 (en) * 2005-05-27 2006-11-30 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
US20060270635A1 (en) * 2005-05-27 2006-11-30 Wallace John L Derivatives of 4- or 5-aminosalicylic acid
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
NZ593132A (en) * 2005-08-24 2013-02-22 Salix Pharmaceuticals Ltd Balsalazide formulations and manufacture and use thereof
US7452872B2 (en) 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
KR101432313B1 (ko) 2005-11-17 2014-08-20 노파르티스 아게 약제학적 조성물
EP1996710B1 (en) * 2006-03-09 2019-08-14 Salix Pharmaceuticals, Inc. Rifaximin anti-rectal dysfunction preparation
JP5421098B2 (ja) * 2006-06-06 2014-02-19 ジーアイケア ファーマ インク． トリメブチン及びｎ−脱メチル化トリメブチンの塩類
US7271253B1 (en) * 2006-08-10 2007-09-18 Apotex Pharmachem Inc. Safe process for the preparation of balsalazide
JPWO2008114831A1 (ja) * 2007-03-20 2010-07-08 国立大学法人 岡山大学 スルホンアミド基を有する抗菌剤
US20090098088A1 (en) * 2007-10-10 2009-04-16 The Procter & Gamble Company Methods And Kits For The Treatment Of Diverticular Conditions
CN102014926A (zh) * 2008-05-01 2011-04-13 宝洁公司 用于治疗炎性肠病的方法和试剂盒
CN105348184B (zh) * 2015-11-26 2020-12-29 苏州统华药品有限公司 一种柳氮磺吡啶的制备方法
IL271777B2 (en) 2017-07-07 2024-09-01 Epicentrx Inc Compositions for parenteral administration of therapeutic agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2270676A (en) * 1936-08-20 1942-01-20 Winthrop Chem Co Inc Sulphonic acid amide compound
US2396145A (en) * 1940-12-14 1946-03-05 Pharmscia Ab Heterocyclic sulphonamido azo compounds
BE791889A (fr) * 1971-11-26 1973-05-24 Pharmacia Ab Nouveaux derives de la pyridine
JPS5353449A (en) * 1976-10-22 1978-05-15 Sofuia Kk Picture type pachinko game machine
US4412992A (en) * 1980-07-21 1983-11-01 Biorex Laboratories Limited 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
CS142691A3 (en) * 1991-05-15 1992-11-18 Vyzk Ustav Farm Biochem Sp Process for preparing 5-//4-/(4',6'-dimethyl-2-pyrimidinyl)sulfamoyl/phenyl/azo/-acetylsalicylic acid
SE9700934D0 (sv) * 1997-03-14 1997-03-14 Astra Ab New formulation

Also Published As

Publication number Publication date
IL154537A0 (en) 2003-09-17
JP5112595B2 (ja) 2013-01-09
MXPA03001786A (es) 2003-06-04
EP1313699B1 (en) 2010-03-10
EP1313699A1 (en) 2003-05-28
CA2421114C (en) 2010-12-07
WO2002018330A1 (en) 2002-03-07
US20020111334A1 (en) 2002-08-15
JP2004507521A (ja) 2004-03-11
DE60141520D1 (de) 2010-04-22
AU2001285489A1 (en) 2002-03-13
IL154537A (en) 2013-07-31
US6458776B1 (en) 2002-10-01
CA2421114A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
ATE460394T1 (de) 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten
EA200400944A1 (ru) Замещенные производные тетрациклина, фармацевтическая композиция и способ лечения субъекта с их использованием
EA200200873A1 (ru) Новые пиперазиновые производные
EA200501098A1 (ru) Антибактериальные агенты
DE60021873D1 (de) Zubereitung zur prophylaxe oder behandlung der demenz-erkrankung enthaltend ein hydroxyzimtsäurederivat oder einen extrakt einer pflanze der gattung angelica, der diese säure enthält.
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
BR9509212A (pt) Composto composição farmacêutica método de inibição de prostaglandina H sintase em um mamífero método de tratamento de uma doença inflamatória em um mamífero e método de tratamento de pirese em um mamífero
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
EA200000871A1 (ru) Ингибиторы фосфолипазных ферментов
BR0109011A (pt) Composto, processo para preparação e uso do mesmo, método para produzir um efeito inibidor de ibat em um animal de sangue quente, e, composição farmacêutica
RU2004110719A (ru) Зздабиторы протеаз, расщепляющих за пролином
CY1105915T1 (el) Παραγωγα θειαζολιου για τη θepαπεια των παθησεων που σχετιζονται με τους ppar
EA200100971A1 (ru) Новые соединения и композиции в качестве ингибиторов протеазы
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
MXPA04000328A (es) Derivados de alfa-hidroxiamida estatina para tratamiento de enfermedad de alzheimer.
DE602007008616D1 (de) Verfahren zur herstellung von 4'-azidocytidinderivaten
WO2002018324A3 (en) Immunoregulatory compounds, derivatives thereof and their use
EA200401528A1 (ru) Производные диарилсульфидов, способ их получения и промежуточные соединения
EA200000804A1 (ru) Мета-азациклические соединения аминобензойной кислоты и их производные, являющиеся ингибиторами интегрина
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
CY1109085T1 (el) Νεα αλατα
EE04564B1 (et) Bifenlamidiini derivaadid, eelravim, vere koagulatsiooniinhibiitor ning proflaktiline ja terapeutiline toimeaine tromboosi v?i emboolia vastu
EA200000741A1 (ru) Новые производные дигидроксигексановой кислоты
DE69510338D1 (de) Azirdin-derivate, deren herstellung und verwendung
ATE326964T1 (de) Aminosäurederivate zur behandlung der alzheimer- krankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties